New Zealand markets closed
  • NZX 50

    11,641.85
    -12.71 (-0.11%)
     
  • NZD/USD

    0.6412
    +0.0038 (+0.60%)
     
  • NZD/EUR

    0.6083
    +0.0031 (+0.50%)
     
  • ALL ORDS

    7,503.50
    -50.50 (-0.67%)
     
  • ASX 200

    7,301.50
    -52.90 (-0.72%)
     
  • OIL

    80.24
    -0.98 (-1.21%)
     
  • GOLD

    1,812.10
    -3.10 (-0.17%)
     
  • NASDAQ

    11,980.31
    -61.59 (-0.51%)
     
  • FTSE

    7,556.23
    -2.26 (-0.03%)
     
  • Dow Jones

    34,395.03
    +0.02 (+0.00%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • Hang Seng

    18,675.35
    -61.09 (-0.33%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • NZD/JPY

    86.0660
    -0.0990 (-0.11%)
     

Goldman Sachs reiterates $2 price target on Bed Bath & Beyond stock

Yahoo Finance Live's Brian Sozzi discusses a Goldman Sachs analyst's decision to reiterate Bed Bath & Beyond stock to Sell.

Video transcript

BRIAN SOZZI: Before we head to break, I want to highlight another very bearish call on the struggling Bed Bath & Beyond out of Goldman Sachs. Analyst Kate McShane reiterated her sell rating and $2 price target on the stock, which assumes 67% downside from current levels. Says McShane, "We continue to believe Bed Bath & Beyond will have a hard time driving customers to its store, especially in the second half, given the amount of competition we expect in the home goods industry." I have more from McShane's note now on the Yahoo! Finance home page, so give it a read and give it a share.